Northwest Biotherapeutics, Inc.
(Other OTC/NBB : NWBO)

( )
NWBO PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
AMGNAmgen, Inc. -1.98%242.591.3%$854.07m
MRNAModerna, Inc. -2.27%67.160.0%$716.87m
IMMUImmunomedics, Inc. 0.14%85.1711.0%$669.53m
NVAXNovavax, Inc. -9.01%101.5796.5%$605.16m
GILDGilead Sciences, Inc. -0.49%63.091.0%$573.14m
ILMNIllumina, Inc. 1.67%273.003.5%$451.06m
REGNRegeneron Pharmaceuticals, Inc. -1.11%565.192.7%$438.62m
BIIBBiogen, Inc. -0.21%272.201.6%$337.47m
VRTXVertex Pharmaceuticals, Inc. -1.41%263.821.9%$321.90m
ALXNAlexion Pharmaceuticals, Inc. -1.82%112.432.0%$278.98m
SRNESorrento Therapeutics, Inc. -10.95%9.601.5%$268.90m
MNTAMomenta Pharmaceuticals, Inc. -0.13%52.293.0%$205.05m
VXRTVaxart, Inc. -17.83%7.190.0%$204.43m
SGENSeattle Genetics, Inc. -1.47%179.276.0%$202.41m
BMRNBioMarin Pharmaceutical, Inc. -1.17%78.434.3%$197.61m

Company Profile

Northwest Biotherapeutics, Inc. is a clinical stage biotechnology company. The firm engages in the development of cancer vaccines designed to treat solid tumor cancers. It also offers a platform technology for DCVax dendritic cell-based vaccines. The company was founded by Alton L. Boynton on March 18, 1996 and is headquartered in Bethesda, MD.